We demonstrated for the first time that ADAM17/PTGS2 facilitates pulmonary fibrogenesis by initiating intracellular ferroptosis and proposed that ADAM17/PTGS2/ferroptosis is a new pathway driving PF, providing a new theoretical basis for further exploration of PF treatment. This evidence concerns the gene ADAM17 and pemphigus foliaceus.